Because MIC-1/GDF15 is so frequently and substantially overexpressed in cancers, and because anti-cancer treatments induce MIC-1/GDF15 expression both in cancer and non-cancer tissues, any effects on tumor behavior may be of high clinical significance. Here, GDF15 is linked to neoplasm.